Thyrocare Technologies Ltd (THYROCARE) Stock Recommendation | Score, Valuation, Technicals & Financial Trend

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

Comparison

Company

Score

Quality

Valuation

Financial

Technical

Vijaya Diagnost.

Metropolis Healt

Thyrocare Tech.

Indegene

Vimta Labs

Syngene Intl.

Krsnaa Diagnost.

Suraksha Diagno.

Poly Medicure

Suven Life Scie.

Nephrocare Healt

Why is Thyrocare Technologies Ltd ?

High Management Efficiency with a high ROE of 23.66%

The company is Net-Debt Free

Poor long term growth as Net Sales has grown by an annual rate of 12.02% and Operating profit at 9.20% over the last 5 years

With a growth in Net Profit of 45.32%, the company declared Very Positive results in Dec 25

The company has declared positive results for the last 8 consecutive quarters
NET SALES(Latest six months) At Rs 412.06 cr has Grown at 20.04%
ROCE(HY) Highest at 34.15%
PBT LESS OI(Q) At Rs 36.57 cr has Grown at 52.95%

With ROE of 23.9, it has a Very Expensive valuation with a 13.6 Price to Book Value

The stock is trading at a premium compared to its peers' average historical valuations
Over the past year, while the stock has generated a return of 52.38%, its profits have risen by 62.4% ; the PEG ratio of the company is 0.8

100% of Promoter Shares are Pledged

In falling markets, high promoter pledged shares puts additional downward pressure on the stock prices

Consistent Returns over the last 3 years

Along with generating 52.38% returns in the last 1 year, the stock has outperformed BSE500 in each of the last 3 annual periods

Real-Time Research Report

Verdict Report

How much should you hold?

Overall Portfolio exposure to Thyrocare Tech. should be less than 10%
Overall Portfolio exposure to Healthcare Services should be less than 30%

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Healthcare Services)

When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock

Is Thyrocare Tech. for you?

High Risk, High Return

Absolute

Risk Adjusted

Volatility

Thyrocare Tech.

52.38%

1.30

40.36%

Sensex

-3.33%

-0.25

13.43%

Quality

Management Risk

Growth

Capital Structure

Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor

Value

Sales Growth (5y)

12.02%

EBIT Growth (5y)

9.20%

EBIT to Interest (avg)

63.41

Debt to EBITDA (avg)

0.17

Net Debt to Equity (avg)

-0.31

Sales to Capital Employed (avg)

1.10

Tax Ratio

30.63%

Dividend Payout Ratio

Pledged Shares

100.00%

Institutional Holding

26.36%

ROCE (avg)

32.53%

ROE (avg)

23.66%

Valuation

Valuation Scorecard

Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors

Factor

Value

P/E Ratio

Industry P/E

Price to Book Value

13.62

EV to EBIT

38.14

EV to EBITDA

29.05

EV to Capital Employed

19.39

EV to Sales

8.97

PEG Ratio

0.80

Dividend Yield

2.04%

ROCE (Latest)

47.70%

ROE (Latest)

23.91%

Loading Valuation Snapshot...

Technicals

Technical key factors

Indicator

Weekly

Monthly

MACD

Mildly Bullish

Mildly Bearish

RSI

No Signal

Bollinger Bands

Bullish

Moving Averages

Mildly Bearish (Daily)

KST

Mildly Bullish

Bullish

Dow Theory

No Trend

OBV

Mildly Bullish

Mildly Bearish

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Technical Movement

Analyse All Technical Factors

Financial Trend

Financial Trend Scorecard

Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

20What is working for the Company

NET SALES(Latest six months)

At Rs 412.06 cr has Grown at 20.04%

ROCE(HY)

Highest at 34.15%

PBT LESS OI(Q)

At Rs 36.57 cr has Grown at 52.95%

PAT(Q)

At Rs 33.89 cr has Grown at 77.4%

0What is not working for the Company

NO KEY NEGATIVE TRIGGERS

Loading Valuation Snapshot...

Here's what is working for Thyrocare Tech.

Profit Before Tax less Other Income (PBT) - Quarterly

At Rs 36.57 cr has Grown at 52.95%

Year on Year (YoY)

MOJO Watch

Near term PBT trend is very positive

PBT less Other Income (Rs Cr)

Profit After Tax (PAT) - Quarterly

At Rs 33.89 cr has Grown at 77.4%

Year on Year (YoY)

MOJO Watch

Near term PAT trend is very positive

PAT (Rs Cr)

Net Sales - Latest six months

At Rs 412.06 cr has Grown at 20.04%

Year on Year (YoY)

MOJO Watch

Near term sales trend is positive

Net Sales (Rs Cr)

Here's what is not working for Thyrocare Tech.

Non Operating Income - Quarterly

Highest at Rs 4.98 cr

in the last five quarters

MOJO Watch

Increased income from non business activities may not be sustainable

Non Operating Income